Ophthalmic interventions offer best value gains

Article

Therapeutic interventions, in particular for neovascular age-related macular degeneration (AMD) offer a better degree of value than any other treatment right across the field of healthcare.

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
A blurred image of an audience in an auditorium where a conference speaker is presenting. Image credit: ©fongleon356 – stock.adobe.com

Don’t miss our editorial advisory board members at the Floretina/ICOOR meeting

Hattie Hayes
December 5th 2024
Article

EAB members from Ophthalmology Times Europe, Ophthalmology Times and Modern Retina are presenting in Florence

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
July 22nd 2024
Podcast
The historic centre of Florence, Italy, surrounded by rolling green hills. Image credit: ©H-AB Photography – stock.adobe.com

The Floretina ICOOR meeting begins in Florence, Italy

Hattie Hayes
December 4th 2024
Article

What to expect from 4 days in the Fortezza de Basso

An AI-generated image of Neuron Cells building a neural network. Image credit: ©Katynn – stock.adobe.com

Adapting our understanding of cerebral visual impairment

By Lynda Charters; Reviewed by Lotfi Merabet, OD, PhD
December 4th 2024
Article

The differential recruitment of the dorsal and ventral visual streams

A group of patients, including a diverse array of men, women and children, sit in a waiting room. Image credit: ©DC Studio – stock.adobe.com

Ethnic background has an impact on glaucoma outcomes

Lynda Charters; Reviewed by Atika Safitri, PhD
December 3rd 2024
Article

Gauging patient perceptions in an ethnically diverse UK cohort

The B Corp certification symbol on a phone, and the B Lab website on a computer. Image credit: ©Timon – stock.adobe.com

Recyclable ophthalmic instrument company HASA OPTIX receives B Corporation certification

Hattie Hayes
December 3rd 2024
Article

The Belgian B Corp company, founded in 2016, is partially owned by Rayner and distributed in over 20 European countries

© 2024 MJH Life Sciences

All rights reserved.